Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Orbital Vascular Inflammation in Ischemic Optic Neuropathy and Giant Cell Arteritis

NCT07206238 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.

NCT NCT07206238
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07206238 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Orbital Vascular Inflammation in Ischemic Optic Neuropathy and Giant Cell Arteritis
Lead sponsor
Rigshospitalet, Denmark
Phase
Observational
Overall status
Recruiting
Start date
January 14, 2026
Completion date
March 30, 2029
Enrollment
122 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

giant cell arteritis (gca), ischemic optic neuropathy, naion - non-arteritic ischemic optic neuropathy